In the Original Investigation titled “Viral Antigen and Inflammatory Biomarkers in Cerebrospinal Fluid in Patients With COVID-19 Infection and Neurologic Symptoms Compared With Control Participants Without Infection or Neurologic Symptoms,”[1] published May 23, 2022, in Figures 1 and 2, the label “Neurosymptomatic patients” had been incorrectly written as “Asymptomatic patients.” This article has been corrected.[1]
Authors: Arvid Edén; Anna Grahn; Daniel Bremell; Anahit Aghvanyan; Pradeepthi Bathala; Dietmar Fuchs; Johanna Gostner; Lars Hagberg; Nelly Kanberg; Sunsanee Kanjananimmanont; Magnus Lindh; Salvia Misaghian; Staffan Nilsson; Michael Schöll; George Sigal; Erika Stentoft; Marie Studahl; Aylin Yilmaz; Mingyue Wang; Martin Stengelin; Henrik Zetterberg; Magnus Gisslén Journal: JAMA Netw Open Date: 2022-05-02